We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+13.06%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.23B
AUM Growth
+$208M
(+5.2%)
Cap. Flow
+$22.5M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181
Avg Time Held Equity + Options
4.4
quarters
Top 10 Avg Time Held Equity + Options
1.5
quarters
Top 20 Avg Time Held Equity + Options
1.6
quarters
Avg Time Held Equity only
4.5
quarters
Top 10 Avg Time Held Equity only
1.5
quarters
Top 20 Avg Time Held Equity only
1.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intra-Cellular Therapies Inc.
ITCI
|
+$383M |
| 2 |
Discover Financial Services
DFS
|
+$224M |
| 3 |
Beacon Roofing Supply, Inc.
BECN
|
+$183M |
| 4 |
Walgreens Boots Alliance
WBA
|
+$110M |
| 5 |
Nordstrom
JWN
|
+$95.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HashiCorp, Inc. Class A Common Stock
HCP
|
+$235M |
| 2 |
Smartsheet Inc.
SMAR
|
+$216M |
| 3 |
Endeavor Group Holdings, Inc.
EDR
|
+$144M |
| 4 |
Summit Materials, Inc. Class A Common Stock
SUM
|
+$103M |
| 5 |
Altair Engineering Inc
ALTR
|
+$97.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.21% |
| 2 | Healthcare | 16.93% |
| 3 | Financials | 12.93% |
| 4 | Industrials | 12.5% |
| 5 | Technology | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Mirum Pharmaceuticals
MIRM
$5.58B
| $1.02M | 0.02% |
22,560
-2,499
| -10% | -$118K |
2023 Q2
7 quarters
|
|
177
Kroger
KR
$36.4B
| $1.02M | 0.02% |
+15,000
| New | +$951K |
2025 Q1
0 quarters
|
|
178
Praxis Precision Medicines
PRAX
$7.26B
| $1.01M | 0.02% |
26,793
+290
| +1% | +$18.1K |
2022 Q1
12 quarters
|
|
179
Arcus Biosciences
RCUS
$3.11B
| $1.01M | 0.02% |
128,688
+52,042
| +68% | +$603K |
2022 Q2
11 quarters
|
|
180
Relay Therapeutics
RLAY
$3.92B
| $1M | 0.02% |
382,900
+52,201
| +16% | +$205K |
2024 Q3
2 quarters
|
|
181
KALA BIO
KALA
$5.68M
| $979K | 0.02% |
3,418
-161
| -4% | -$60.9K |
2024 Q1
4 quarters
|
|
182
Costco
COST
$420B
| $946K | 0.02% |
+1,000
| New | +$975K |
2025 Q1
0 quarters
|
|
183
DELISTED
Terns Pharmaceuticals
TERN
| $928K | 0.02% |
336,144
+195,844
| +140% | +$800K |
2024 Q3
2 quarters
|
|
184
PUT
Transocean
RIG
$6.15B
| $927K | 0.02% |
803,400
| – | – |
2018 Q2
27 quarters
|
|
185
Annexon
ANNX
$762M
| $901K | 0.02% |
466,819
+147,935
| +46% | +$492K |
2022 Q1
12 quarters
|
|
186
DELISTED
Day One Biopharmaceuticals
DAWN
| $898K | 0.02% |
113,250
+63,230
| +126% | +$681K |
2024 Q4
1 quarter
|
|
187
Scholar Rock
SRRK
$5.14B
| $888K | 0.02% |
+27,617
| New | +$1.06M |
2025 Q1
0 quarters
|
|
188
Aura Biosciences
AURA
$678M
| $885K | 0.02% |
151,108
+14,592
| +11% | +$110K |
2023 Q2
7 quarters
|
|
189
IQVIA
IQV
$42.8B
| $882K | 0.02% |
+5,000
| New | +$970K |
2025 Q1
0 quarters
|
|
190
BridgeBio Pharma
BBIO
$12.8B
| $881K | 0.02% |
25,492
-35,626
| -58% | -$1.2M |
2024 Q2
3 quarters
|
|
191
Edgewise Therapeutics
EWTX
$4.24B
| $880K | 0.02% |
+40,014
| New | +$1.05M |
2025 Q1
0 quarters
|
|
192
AnaptysBio
ANAB
$1.37B
| $875K | 0.02% |
+47,051
| New | +$785K |
2025 Q1
0 quarters
|
|
193
Skillsoft
SKIL
$55.6M
| $802K | 0.02% |
41,692
| – | – |
2023 Q4
5 quarters
|
|
194
Edwards Lifesciences
EW
$49.1B
| $791K | 0.02% |
10,920
+1,160
| +12% | +$83K |
2024 Q3
2 quarters
|
|
195
UWM Holdings
UWMC
$373M
| $781K | 0.02% |
143,000
| – | – |
2024 Q4
1 quarter
|
|
196
enVVeno Medical
NVNO
$6.08M
| $779K | 0.02% |
8,458
| – | – |
2022 Q1
12 quarters
|
|
197
DELISTED
Akero Therapeutics
AKRO
| $761K | 0.02% |
+18,800
| New | +$797K |
2025 Q1
0 quarters
|
|
198
Alcon
ALC
$31B
| $759K | 0.02% |
8,000
-6,039
| -43% | -$542K |
2024 Q1
4 quarters
|
|
199
PUT
MGM Resorts International
MGM
$7.36B
| $752K | 0.02% |
82,600
-42,400
| -34% | -$1.42M |
2023 Q1
8 quarters
|
|
200
Syndax Pharmaceuticals
SNDX
$1.52B
| $730K | 0.02% |
59,438
-30,794
| -34% | -$434K |
2023 Q4
5 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q1 2025 Portfolio in Review
As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
UBS O'Connor's Q1 2025 filing shows 83 new, 81 increased, 97 reduced and 181 closed positions. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $235M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
- UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
- UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
- UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
- UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
- UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
- UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.
Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.